PROS1 and COVID-19: The COVID-19 vaccine developed by Johnson and Johnson’s/Janssen (Ad.26.COV2.S) is a recombinant, replication-incompetent adenovirus serotype 26 (Ad26) vector vaccine, which encodes the stabilized prefusion S protein of SARS-CoV-2.